Loading reports catalog...
Loading reports catalog...
Access deep-dive research across global industry sectors to empower your strategic decision-making with data-driven insights.
Browse our extensive repository of premium market research reports spanning multiple global industries. Gain access to critical intelligence, market sizing, strategic forecasts, and comprehensive competitive analysis. We equip businesses with data-driven insights to navigate complex market dynamics, capitalize on emerging opportunities, and secure long-term growth.
Showing 100 Results
The U.S. midline catheter market was evaluated at USD 1,168.43 million in 2025 and is projected to expand at a CAGR of 5.3% from USD 1,220.66 million in 2026 to USD 1,946.06 million in 2035. The strong market growth is propelled by the escalating demand for safer and extended-duration intravenous access, a rise in hospital admissions, and a heightened preference for less invasive vascular access devices. Moreover, the increasing elderly population in the U.S. is leading to elevated hospitalization rates and a heightened need for vascular access solutions that minimize complications such as phlebitis and bloodstream infections related to catheters.
The U.S. low sterilisation equipment market size was estimated at USD 974.22 million in 2025 and is expected to expand at a CAGR of 10.5% from USD 1,067.25 million in 2026 to USD 2,621.14 million in 2035. The robust market growth is mainly fueled by the growing need for sterilizing heat- and moisture-sensitive medical instruments, increasing numbers of surgical procedures, and strict infection control standards in healthcare settings. Furthermore, the growing prevalence of healthcare-associated infections (HAIs), the increasing use of minimally invasive techniques, and a heightened focus on adhering to sterilization standards set by regulatory authorities are driving market expansion.
The global stool management systems market was evaluated at USD 1,771.66 million in 2025 and is projected to grow with a CAGR of 5.1% from USD 1,842.52 million in 2026 to USD 2,882.57 million in 2035. The strong market expansion is driven by the rising frequency of fecal incontinence, heightened occurrence of critically ill patients needing extended intensive care, and increasing focus on infection prevention in medical environments. Moreover, the increasing focus on decreasing hospital-acquired infections (HAIs), especially in intensive care units (ICUs), is driving the implementation of closed-loop stool management systems that aid in minimising skin breakdown, preventing cross-contamination, and enhancing patient hygiene.
The continuous glucose monitoring devices market was valued at USD 13.5 billion in 2025, and is expected to grow at a CAGR of 15.1% from USD 15.4 billion in 2026 to USD 54.9 billion in 2035. The strong market expansion is mainly fueled by the escalating global incidence of diabetes, heightened awareness regarding the significance of continuous glucose monitoring, and the increasing use of advanced diabetes management technologies. Additionally, technological innovations like factory-tuned sensors, wearable and minimally invasive CGM devices, smartphone integration, cloud-based data sharing, and AI-driven glucose analysis are improving user convenience and clinical results.
The patient temperature management market was estimated at USD 4,020.71 million in 2025 and is expected to expand at a CAGR of 8.1%, rising from USD 4,311.81 million in 2026 to USD 8,719.68 million by 2035. The robust market growth is driven by the increasing volume of surgical interventions, higher occurrence of cardiac arrest situations, and escalating need for efficient post-operative and critical care management options. Moreover, the increasing use of targeted temperature management (TTM) in post-cardiac arrest treatment, neurological injury management, and perioperative care is considerably contributing to market growth.
The U.S. cranial implants market was estimated at USD 521.83 million in 2025 and is expected to expand at a CAGR of 5.3%, rising from USD 545.15 million in 2026 to USD 869.13 million by 2035. The strong market growth is mainly fueled by the rising occurrence of traumatic brain injuries (TBI), the escalating number of cranial reconstruction surgeries, and the increasing prevalence of neurological conditions that necessitate cranioplasty. Additionally, improvements in individualised 3D-printed cranial implants, biomaterials like titanium and PEEK, along with computer-assisted surgical planning, are enhancing surgical results and accelerating market expansion.
Stay informed with updates on related market reports and key industry topics.